Abstract
Ets family transcription factors, characterized by an evolutionary conserved Ets domain, play important roles in cell development, cell differentiation, apoptosis and tissue remodeling. All members of this family have an activation or a repression domain for DNA binding. The Ets domain has been shown to bind 5-GGAA/T-3 core motif of DNA by its wHTH (winged helix-turn-helix) structure, as determined by NMR or X-Ray crystallography analysis. A number of Ets transcription factors have been shown to be involved or directly implicated in the pathogenesis of a wide spectrum of human cancers. They are thus potential molecular targets for selective cancer therapy. Computer simulations using molecular dynamics allows monitoring the dynamics of individual atoms, thereby giving a unique insight into the structural flexibility of binary complexes between Ets-domain and a specific DNA sequence that cannot be easily extracted from laboratory experiments. Moreover, an understanding of structural motifs that influence the specificity of Ets domains is essential for antitumor drug design. Here we describe molecular and structural studies that provide a detailed description of the direct and indirect readout mechanisms of DNA recognition by Ets domains, a conserved mechanism observed in other DNA-protein complexes.
Keywords: Molecular dynamics, Ets domain, DNA binding site, structure
Current Bioinformatics
Title: Molecular Dynamics and Structural Studies of the Ets Domain-DNA Complexes
Volume: 2 Issue: 3
Author(s): Rafael A. Caceres, Claudia P. Nunes, Walter F. de Azevedo Jr., Luiz A. Basso and Diogenes S. Santos
Affiliation:
Keywords: Molecular dynamics, Ets domain, DNA binding site, structure
Abstract: Ets family transcription factors, characterized by an evolutionary conserved Ets domain, play important roles in cell development, cell differentiation, apoptosis and tissue remodeling. All members of this family have an activation or a repression domain for DNA binding. The Ets domain has been shown to bind 5-GGAA/T-3 core motif of DNA by its wHTH (winged helix-turn-helix) structure, as determined by NMR or X-Ray crystallography analysis. A number of Ets transcription factors have been shown to be involved or directly implicated in the pathogenesis of a wide spectrum of human cancers. They are thus potential molecular targets for selective cancer therapy. Computer simulations using molecular dynamics allows monitoring the dynamics of individual atoms, thereby giving a unique insight into the structural flexibility of binary complexes between Ets-domain and a specific DNA sequence that cannot be easily extracted from laboratory experiments. Moreover, an understanding of structural motifs that influence the specificity of Ets domains is essential for antitumor drug design. Here we describe molecular and structural studies that provide a detailed description of the direct and indirect readout mechanisms of DNA recognition by Ets domains, a conserved mechanism observed in other DNA-protein complexes.
Export Options
About this article
Cite this article as:
Caceres A. Rafael, Nunes P. Claudia, de Azevedo Jr. F. Walter, Basso A. Luiz and Santos S. Diogenes, Molecular Dynamics and Structural Studies of the Ets Domain-DNA Complexes, Current Bioinformatics 2007; 2 (3) . https://dx.doi.org/10.2174/157489307781662141
DOI https://dx.doi.org/10.2174/157489307781662141 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Novel Rational Drug Design Strategies with Potential to Revolutionize Malaria Chemotherapy
Current Medicinal Chemistry Vasoproliferation and Antiproliferative Treatment Options in Pulmonary Arterial Hypertension
Recent Patents on Cardiovascular Drug Discovery Known Triterpenes and their Derivatives as Scaffolds for the Development of New Therapeutic Agents for Cancer
Current Medicinal Chemistry Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
Current Cardiology Reviews Therapeutic Potential of Endophytic Compounds: A Special Reference to Drug Transporter Inhibitors
Current Topics in Medicinal Chemistry Targeting Kinases in Cancer Therapies: Adverse Effects on Blood Platelets
Current Pharmaceutical Design Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders
Current Pharmaceutical Design In Silico Analysis of Amino Acid Sequences in Relation to Specificity and Physiochemical Properties of Mesophilic and Thermophilic Antileukemic L-Asparaginases
Current Biotechnology Sporadic Porphyria in a Patient with Stage II Melanoma Treated with Interferon α
Current Drug Safety Gene Therapy for Pituitary Tumors
Current Gene Therapy Insight γ-Secretase: Structure, Function, and Role in Alzheimer’s Disease
Current Drug Targets Interferon-Alpha in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Status and Perspectives
Current Drug Targets Angiogenesis in Chronic Lymphocytic Leukemia
Current Angiogenesis (Discontinued) Development of Doxorubicin Quantification by Reductive Amination
Current Analytical Chemistry Bioactive Polyphenols from Grapes and Wine Emphasized with Resveratrol
Current Pharmaceutical Design Inhibitors of the Sphingosine Kinase Pathway as Potential Therapeutics
Current Cancer Drug Targets Imatinib and Its Successors – How Modern Chemistry has Changed Drug Development
Current Pharmaceutical Design MicroRNAs in Cancer: Small Molecules, Big Chances
Anti-Cancer Agents in Medicinal Chemistry Do Not Say Ever Never More: The Ins and Outs of Antiangiogenic Therapies
Current Pharmaceutical Design Chalcone Derivatives Activate and Desensitize the Transient Receptor Potential Ankyrin 1 Cation Channel, Subfamily A, Member 1 TRPA1 Ion Channel: Structure-Activity Relationships in vitro and Anti-Nociceptive and Anti-inflammatory Activity in vivo
CNS & Neurological Disorders - Drug Targets